Lactobacillus Brevis CD2 Preventing Oral Mucositis
NCT02085694
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Mucositis
Interventions
DRUG:
Lactobacillus brevis CD2
Sponsor
Catholic University of the Sacred Heart